Cost of Treatment of Multiple Myeloma in a Public Sector Tertiary Care Hospital of North India

Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, MacIntyre M et al (2015) The global burden of cancer 2013. JAMA Oncol 1(4):505–527

Takiar R, Nadayil D, Nandakumar A (2010) Projections of number of cancer cases in India (2010–2020) by cancer groups. Asian Pac J Cancer Prev 11:1045–1049

Raab M, Podar K, Breitkreutz I, Richardson P, Anderson K (2009) Multiple myeloma. Lancet 374:324–339

Ghalaut P, Chaudhuri S, Singh R (2013) Recent advances in diagnosis and management of multiple myeloma: an update. The Association of Physicians of India, Medicine Update, India

Lu J, Hou J, Liu KY, Parmar S, De La Fuente A, Andersson B et al (2016) Asia-Pacific Hematology Consortium Report on approach to multiple myeloma. Survey results from the 6th international hematologic malignancies conference: bridging the gap 2015, Beijing, China. Leuk Lymphoma 57(7):1534–1538

Yanamandra U, Khattry N, Kumar S, Raje N, Jain A, Jagannath S et al (2017) Consensus in the management of multiple myeloma in India at myeloma state of the art 2016 conference. Indian J Hematol Blood transfus 33(1):15–21

Barlogie B, Hall R, Zander A, Dicke K, Alexanian R (1986) High-dose melphalan with autologous bone marrow transplantation for multiple myeloma. Blood 67(5):1298–1301

Fermand JP, Chevret S, Ravaud P, Divine M, Leblond V, Dreyfus F et al (1993) High-dose chemoradiotherapy and autologous blood stem cell transplantation in multiple myeloma: results of a phase II trial involving 63 patients. Blood 82(7):2005–2009

Cunningham D, Paz-Ares L, Milan S, Powles R, Nicolson M, Hickish T et al (1994) High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma. J Clin Oncol 12(4):759–763

Harousseau JL, Attal M, Divine M, Marit G, Leblond V, Stoppa AM et al (1995) Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: a report of the French Registry on autologous transplantation in multiple myeloma. Blood 85(11):3077–3085

Attal M, Harousseau JL, Stoppa AM, Sotto JJ, Fuzibet JG, Rossi JF et al (1996) A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais Du Myelome. N Engl J Med 335(2):91–97

Child JA, Morgan GJ, Davies FE, Owen RG, Bell SE, Hawkins K et al (2003) High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med 348(19):1875–1883

Kumar L, Raju GM, Ganessan K, Shawgi S, Menon H, Wadhwa J et al (2003) High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma. Natl Med J India 16(1):16–21

Koreth J, Cutler CS, Djulbegovic B, Behl R, Schlossman RL, Munshi NC et al (2007) High-dose therapy with single autologous transplantation versus chemotherapy for newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials. Biol Blood Marrow Transplant 13(2):183–196

Kumar L, Ghosh J, Ganessan P, Gupta A, Hariprasad R, Kochupillai V (2009) High-dose chemotherapy with autologous stem cell transplantation for multiple myeloma: what predicts the outcome? Experience from a developing country. Bone Marrow Transplant 43(6):481–489

Prinja S, Kaur G, Malhotra P, Jyani G, Ramachandran R, Bahuguna P et al (2017) Cost-effectiveness of autologous stem cell treatment as compared to conventional chemotherapy for treatment of multiple myeloma in India. Indian J Hematol Blood Transfus. doi: 10.1007/s12288-017-0776-1

Prinja S, Jagnoor J, Chauhan AS, Aggarwal S, Nguyen H, Ivers R (2016) Economic burden of hospitalization due to injuries in North India: a cohort study. Int J Environ Res Public Health. doi: 10.3390/ijerph13070673

Hendriks ME, Kundu P, Boers AC, Bolarinwa OA, Te Pas MJ, Akande TM et al (2014) Step-by-step guideline for disease-specific costing studies in low- and middle-income countries: a mixed methodology. Global Health Action 7:23573

Beck EJ, Harling G, Gerbase S, DeLay P (2010) The cost of treatment and care for people living with HIV infection: implications of published studies, 1999–2008. Curr Opin HIV AIDS 5(3):215–224

Adam T, Bishai D, Khan M, Evans D (2004) Methods for the costing component of multi-country evaluation of IMNCI. World Health Organization, Geneva

Prinja S, Jeet G, Verma R, Kumar D, Bahuguna P, Kaur M et al (2014) Economic analysis of delivering primary health care services through community health workers in 3 North Indian states. PLoS ONE 9(3):e91781

Prinja S, Mazumder S, Taneja S, Bahuguna P, Bhandari N, Mohan P et al (2013) Cost of delivering child health care through community level health workers: how much extra does IMNCI program cost? J Trop Pediatr 59(6):489–495

Prinja S, Manchanda N, Mohan P, Gupta G, Sethy G, Sen A et al (2013) Cost of neonatal intensive care delivered through district level public hospitals in India. Indian Pediatr 50(9):839–846

Prinja S, Gupta A, Verma R, Bahuguna P, Kumar D, Kaur M et al (2016) Cost of delivering health care services in public sector primary and community health centres in North India. PLoS ONE 11(8):e0160986

Prinja S, Bahuguna P, Gupta R, Sharma A, Rana SK, Kumar R (2015) Coverage and financial risk protection for institutional delivery: how universal is provision of maternal health care in India? PLoS ONE 10(9):e0137315

Gupta I, Chowdhury S, Prinja S, Trivedi M (2016) Out-of-pocket spending on out-patient care in India: assessment and options based on results from a district level Survey. PLoS ONE 11(11):e0166775

Prinja S, Gupta R, Bahuguna P, Sharma A, Kumar Aggarwal A, Phogat A et al (2017) A composite indicator to measure universal health care coverage in India: way forward for post-2015 health system performance monitoring framework. Health Policy Plan 32(1):43–56

ISPOR (2016) Pharmacoeconomics and outcomes research guidelines for India PEOR Guidelines 2016. https://www.ispor.org/consortiums/asia/PEGuidelines_India_March2016.pdf

Sangwan A, Prinja S, Aggarwal S, Jagnoor J, Bahuguna P, Ivers R. Cost of trauma care in secondary and tertiary care public sector hospitals in north India. Appl Health Eco Health Policy. 2017. doi: 10.1007/s40258-017-0329-7

The Economic Times (2015) Forex rates 2015. http://economictimes.indiatimes.com/markets/forex

Mishra V, Andresen S, Brinch L, Kvaloy S, Ernst P, Lonset MK et al (2005) Cost of autologous peripheral blood stem cell transplantation: the Norwegian experience from a multicenter cost study. Bone Marrow Transplant 35(12):1149–1153

Sharma SK, Choudhary D, Gupta N, Dhamija M, Khandelwal V, Kharya G et al (2014) Cost of hematopoietic stem cell transplantation in India. Mediterr J Hematol Infect Dis 6(1):e2014046

Mukhopadhyay A, Gupta P, Basak J, Chakraborty A, Bhattacharyya D, Mukhopadhyay S et al (2012) Stem cell transplant: an experience from eastern India. Indian J Med Paediatr Oncol 33(4):203–209

Garg CC, Karan AK (2009) Reducing out-of-pocket expenditures to reduce poverty: a disaggregated analysis at rural–urban and state level in India. Health Policy Plan 24(2):116–128

Bhojani U, Thriveni B, Devadasan R, Munegowda C, Devadasan N, Kolsteren P et al (2012) Out-of-pocket healthcare payments on chronic conditions impoverish urban poor in Bangalore, India. BMC Public Health 12:990

NSSO (2015) Key indicators of social consumption in India Health NSS 71st Round (January–June 2014). Ministry of Statistical and Programme Implementation, New Delhi